Jazz Pharmaceuticals plc — Director's Dealing 2017

Apr 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2017-04-10

Reporting Person: WILSON KAREN J (SVP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-10	Ordinary Shares	M	4750	$59.13	Acquired	27158	Direct
2017-04-10	Ordinary Shares	S	4750	$152.24	Disposed	22408	Direct
2017-04-10	Ordinary Shares	M	6708	$46.83	Acquired	29116	Direct
2017-04-10	Ordinary Shares	S	6708	$152.24	Disposed	22408	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-10	Non-Qualified Stock Option (right to buy)	$46.83	M	6708	Disposed	2022-08-08	Ordinary Shares (6708)	Direct
2017-04-10	Non-Qualified Stock Option (right to buy)	$59.13	M	4750	Disposed	2023-03-04	Ordinary Shares (4750)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: This non-qualified stock option is part of an option granted on August 9, 2012 that consisted of an incentive stock option exercisable for 3,048 ordinary shares and this non-qualified stock option exercisable for 26,952 ordinary shares. The options were fully vested as of August 9, 2016.

F3: This non-qualified stock option is part of an option granted on March 5, 2013 that consisted of an incentive stock option exercisable for 750 ordinary shares and this non-qualified stock option exercisable for 11,250 ordinary shares. The options were fully vested as of March 5, 2017.